David Fitchett

2 ta ish

University of Toronto

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

   Bernard Zinman, Christoph Wanner, John M. Lachin +9

   Maqola20156 iqtibos

   ABIABI:AkademIndex/2026.other.282498

2. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

   G.B. John Mancini, Steven K. Baker, Jean Bergeron +9

   Sharh maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.407888